Latest Regulatory News

Tamboran Resources appoints Chairman Dick Stoneburner as interim CEO following Joel Riddle’s departure, while adding two seasoned energy executives to its board as it advances gas production plans in the Beetaloo Basin.

Ionic Rare Earths’ Brazilian joint venture, Viridion, has advanced to the next phase of securing a substantial US$900 million funding package from Brazilian government agencies to develop rare earth refining and recycling facilities.

Artrya has launched its AI-powered Salix Coronary Anatomy platform in the U.S. and submitted its Coronary Plaque module for FDA clearance, marking a key step in its commercial expansion. A new five-year contract with Tanner Health signals the start of U.S. revenues.

Viridis Mining and Minerals has locked in a strategic US$30 million equity funding partnership with leading Brazilian asset managers to accelerate its Colossus Rare Earth Project towards production.

OD6 Metals has reported strong high-grade copper results from its maiden drilling at Gulf Creek, NSW, alongside progress in rare earth metallurgical testing and closure of a regulatory investigation.

Elanor Investors Group announces a $125 million strategic investment from Rockworth Capital Partners to stabilise its balance sheet and fund growth, including the acquisition of Singapore’s Firmus Capital.

Nova Minerals supports the permit application for the West Susitna Access Road, a vital infrastructure project set to enhance mining access and economic growth in Alaska’s resource-rich region.

Elanor Investors Group announces a $125 million recapitalisation through an expanded alliance with Rockworth Capital Partners, including the acquisition of Singapore’s Firmus Capital and a strategic shift towards Pan-Asian real estate markets.

Stanmore Resources has reported a robust recovery in its June quarter operations with increased coal production, zero serious safety incidents, and positive cash flow, despite challenging weather conditions. The company maintains its full-year production guidance, signaling resilience amid market uncertainties.

Radiopharm Theranostics has received FDA clearance to begin a Phase I clinical trial for RV-01, a novel radiopharmaceutical targeting the 4Ig isoform of B7-H3 in solid tumors, marking a significant step forward in cancer treatment innovation.

Zenith Minerals reports a landmark quarter with a 41% increase in gold resources at Dulcie Far North, a strategic land acquisition, and a successful A$3.5 million entitlement offer to accelerate exploration.

Jcurve Solutions has raised $1 million through a strategic share placement at a significant premium, bringing on a new investor with deep Oracle NetSuite expertise and appointing a nominee director to its board.